World's Most Advanced Treatment Guidance For Drug-Resistant Cancers
What
Encyclopedic multi-analyte tumor profiling to identify functional and molecular features of the tumor which then inform selection of personalized anti-cancer treatment regimens.
For Whom
Patients with advanced or difficult-to-treat cancers, especially where the cancer is not responding to treatments.
How
Tumor components including malignant cells, proteins, DNA and RNA are isolated from tumor tissue and/or blood, analyzed by molecular and functional assays to identify features associated with response (or lack of response) to anti-cancer agents. These findings are integrated to generate patient-specific treatment regimens.
Why
Exacta™'s comprehensive, multi-dimensional and in-depth analysis of the cancer provides a detailed insight into tumor mechanisms. Such information has been clinically proven to help inform selection of safe and efficacious treatment regimens in cancers that do not respond to standard treatments.
Advantages
- Clinically proven to inform the selection of safe and efficacious treatments.
- Includes assessment of all molecular biomarkers indicated in the National Comprehensive Cancer Network (NCCN) guidelines.
- Evaluates additional clinically relevant biomarkers.
- Chemo-response profiling of live tumor / tumor associated cells aids the accurate selection of chemotherapy drugs.
- Guides treatment selection in label compliant as well as off-label settings.
Explore
Explore
A Revolutionary Blood Test To Detect Cancer Early,
So That It Could Be Cured.
USA
10 Medawar Road,
The Surrey Research Park, Guildford,
Surrey, GU2 7AE, United Kingdom
Lessingweg1,
Bayreuth 95447,
Germany
Ambad, Nashik,
Maharashtra – 422010
India